| Dr Kelly Zook, MD | |
|
Christiana Care Health System, Department Of Neonatology, Newark, DE 19718-0001 | |
| (302) 733-2410 | |
| Not Available |
| Full Name | Dr Kelly Zook |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | Christiana Care Health System, Newark, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366579807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | C7-0003261 (Delaware) | Secondary |
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 54759 (Connecticut) | Primary |
| Entity Name | The Nemours Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386658615 PECOS PAC ID: 9537072483 Enrollment ID: O20040109000252 |
News Archive
New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, identified key clinical features of chronic nonbacterial osteomyelitis (CNO), which leads to an important step toward the development of much-needed classification criteria for a disease that affects children and young adults worldwide.
Scientists from Nanyang Technological University have developed a new stroke rehabilitation device which greatly improves recovery in stroke patients.
A new approach to treating pancreatic cancer using 'educated killer cells' has shown promise, according to early research by Queen Mary University of London.
Hanger Orthopedic Group, Inc. announced today the pricing of the previously announced public offering of 2,000,000 shares of its common stock by Ares Corporate Opportunities Fund, L.P. at a public offering price of $20.00 per share. The transaction is expected to close on December 15, 2010. The shares sold were a portion of the currently outstanding shares issued to Ares in August 2008 in connection with the conversion of all of Hanger's Series A Convertible Preferred Stock into common stock.
The plague, bacterial dysentery, and cholera have one thing in common: These dangerous diseases are caused by bacteria which infect their host using a sophisticated injection apparatus. Through needle-like structures, they release molecular agents into their host cell, thereby evading the immune response.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelly Zook, MD Christiana Care Health System, Department Of Neonatology, Newark, DE 19718-0001 Ph: (302) 733-2410 | Dr Kelly Zook, MD Christiana Care Health System, Department Of Neonatology, Newark, DE 19718-0001 Ph: (302) 733-2410 |
News Archive
New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, identified key clinical features of chronic nonbacterial osteomyelitis (CNO), which leads to an important step toward the development of much-needed classification criteria for a disease that affects children and young adults worldwide.
Scientists from Nanyang Technological University have developed a new stroke rehabilitation device which greatly improves recovery in stroke patients.
A new approach to treating pancreatic cancer using 'educated killer cells' has shown promise, according to early research by Queen Mary University of London.
Hanger Orthopedic Group, Inc. announced today the pricing of the previously announced public offering of 2,000,000 shares of its common stock by Ares Corporate Opportunities Fund, L.P. at a public offering price of $20.00 per share. The transaction is expected to close on December 15, 2010. The shares sold were a portion of the currently outstanding shares issued to Ares in August 2008 in connection with the conversion of all of Hanger's Series A Convertible Preferred Stock into common stock.
The plague, bacterial dysentery, and cholera have one thing in common: These dangerous diseases are caused by bacteria which infect their host using a sophisticated injection apparatus. Through needle-like structures, they release molecular agents into their host cell, thereby evading the immune response.
› Verified 1 days ago
Dr. Tracey A. Henderson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4755 Ogletown-stanton Road, Map 1, Suite 116, Newark, DE 19718 Phone: 302-733-4200 Fax: 302-733-2711 | |
Dr. Anna Kolano, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Nemours Pediatrics Peoples Plaza, 1400 Peoples Plaza Suite 300, Newark, DE 19702 Phone: 302-836-7820 Fax: 302-836-7826 | |
Dr. Ann Marie Masciantonio, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4735 Ogletown Stanton Rd, M.a.p. #2, Suite 1116, Newark, DE 19713 Phone: 302-368-8653 Fax: 302-368-8836 | |
Robert G Locke, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4745 Ogletown Stanton Rd, Suite 217 Medical Arts Pavilion One, Newark, DE 19713 Phone: 302-733-2374 Fax: 302-733-2602 | |
Anna P. Nadhan, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4735 Ogletown Stanton Rd Ste 1116, Newark, DE 19713 Phone: 302-368-8612 Fax: 302-368-4384 | |
Lauren Margaret Edgar, CPNP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 875 Aaa Blvd, Newark, DE 19713 Phone: 302-918-6400 | |
Dr. Amanda J Kay, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Christiana Hospital - Dept Of Pediatrics, Newark, DE 19718 Phone: 302-733-6500 Fax: 302-733-2711 |